Tags

Type your tag names separated by a space and hit enter

[Results of the treatment of gastroesophageal reflux and peptic esophagitis using cisapride].
An Esp Pediatr 1990; 32(6):485-8AE

Abstract

Cisapride is a new prokinetic agent that acts at gastric emptying, esophagic peristalsis and the pressure of the low esophagic sphincter. In the present study we grave Cisapride for 12 weeks to 34 patients with severe pathologic gastroesophageal reflux and/or peptic esophagitis. The results show an important improvement of the clinic, pH monitoring, endoscopic and histologic alterations.

Authors+Show Affiliations

Unidad de Gastroenterología y Nutrición, Hospital Infantil de la Seguridad Social La Paz, Madrid.No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article

Language

spa

PubMed ID

2221622

Citation

Carrasco Gandía, S, et al. "[Results of the Treatment of Gastroesophageal Reflux and Peptic Esophagitis Using Cisapride]." Anales Espanoles De Pediatria, vol. 32, no. 6, 1990, pp. 485-8.
Carrasco Gandía S, Lama Moré R, Prieto Bozano G, et al. [Results of the treatment of gastroesophageal reflux and peptic esophagitis using cisapride]. An Esp Pediatr. 1990;32(6):485-8.
Carrasco Gandía, S., Lama Moré, R., Prieto Bozano, G., & Polanco Allue, I. (1990). [Results of the treatment of gastroesophageal reflux and peptic esophagitis using cisapride]. Anales Espanoles De Pediatria, 32(6), pp. 485-8.
Carrasco Gandía S, et al. [Results of the Treatment of Gastroesophageal Reflux and Peptic Esophagitis Using Cisapride]. An Esp Pediatr. 1990;32(6):485-8. PubMed PMID: 2221622.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Results of the treatment of gastroesophageal reflux and peptic esophagitis using cisapride]. AU - Carrasco Gandía,S, AU - Lama Moré,R, AU - Prieto Bozano,G, AU - Polanco Allue,I, PY - 1990/6/1/pubmed PY - 1990/6/1/medline PY - 1990/6/1/entrez SP - 485 EP - 8 JF - Anales espanoles de pediatria JO - An. Esp. Pediatr. VL - 32 IS - 6 N2 - Cisapride is a new prokinetic agent that acts at gastric emptying, esophagic peristalsis and the pressure of the low esophagic sphincter. In the present study we grave Cisapride for 12 weeks to 34 patients with severe pathologic gastroesophageal reflux and/or peptic esophagitis. The results show an important improvement of the clinic, pH monitoring, endoscopic and histologic alterations. SN - 0302-4342 UR - https://www.unboundmedicine.com/medline/citation/2221622/[Results_of_the_treatment_of_gastroesophageal_reflux_and_peptic_esophagitis_using_cisapride]_ L2 - http://www.diseaseinfosearch.org/result/2996 DB - PRIME DP - Unbound Medicine ER -